Literature DB >> 31826841

The human papillomavirus 16 E5 gene potentiates MmuPV1-Dependent pathogenesis.

Alexandra D Torres1, Megan E Spurgeon1, Andrea Bilger1, Simon Blaine-Sauer1, Aayushi Uberoi1, Darya Buehler2, Stephanie M McGregor2, Ella Ward-Shaw1, Paul F Lambert3.   

Abstract

The papillomavirus E5 gene contributes to transformation and tumorigenesis; however, its exact function in these processes and viral pathogenesis is unclear. While E5 is present in high-risk mucosotropic HPVs that cause anogenital and head and neck cancers, it is absent in cutaneous HPVs and the recently discovered mouse papillomavirus (MmuPV1), which causes papillomas and squamous cell carcinomas of the skin and mucosal epithelia in laboratory mice. We infected K14E5 transgenic mice, which express the high-risk mucosotropic HPV16 E5 gene in stratified epithelia, with MmuPV1 to investigate the effects of E5 on papillomavirus-induced pathogenesis. Skin lesions in MmuPV1-infected K14E5 mice had earlier onset, higher incidence, and reduced frequency of spontaneous regression compared to those in non-transgenic mice. K14E5 mice were also more susceptible to cervicovaginal cancers when infected with MmuPV1 and treated with estrogen compared to non-transgenic mice. Our studies support the hypothesis that E5 contributes to papillomavirus-induced pathogenesis.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  E5; Human papillomavirus; Mouse papillomavirus; Oncogene; Pathogenesis

Mesh:

Substances:

Year:  2019        PMID: 31826841      PMCID: PMC7024000          DOI: 10.1016/j.virol.2019.12.002

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  41 in total

1.  Human papillomavirus type 31 E5 protein supports cell cycle progression and activates late viral functions upon epithelial differentiation.

Authors:  Frauke Fehrmann; David J Klumpp; Laimonis A Laimins
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

2.  Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments.

Authors:  Hans-Ulrich Bernard; Robert D Burk; Zigui Chen; Koenraad van Doorslaer; Harald zur Hausen; Ethel-Michele de Villiers
Journal:  Virology       Date:  2010-03-05       Impact factor: 3.616

3.  HPV16 E5 protein disrupts the c-Cbl-EGFR interaction and EGFR ubiquitination in human foreskin keratinocytes.

Authors:  Benyue Zhang; Anjaiah Srirangam; David A Potter; Ann Roman
Journal:  Oncogene       Date:  2005-04-07       Impact factor: 9.867

Review 4.  Papillomaviruses and cancer: from basic studies to clinical application.

Authors:  Harald zur Hausen
Journal:  Nat Rev Cancer       Date:  2002-05       Impact factor: 60.716

5.  Codon optimization of the HPV-16 E5 gene enhances protein expression.

Authors:  Gary L Disbrow; Iruvanti Sunitha; Carl C Baker; John Hanover; Richard Schlegel
Journal:  Virology       Date:  2003-06-20       Impact factor: 3.616

6.  Requirement for estrogen receptor alpha in a mouse model for human papillomavirus-associated cervical cancer.

Authors:  Sang-Hyuk Chung; Kerri Wiedmeyer; Anny Shai; Kenneth S Korach; Paul F Lambert
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

7.  The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes.

Authors:  S W Straight; P M Hinkle; R J Jewers; D J McCance
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

8.  Dissection of human papillomavirus E6 and E7 function in transgenic mouse models of cervical carcinogenesis.

Authors:  Rebeccah R Riley; Stefan Duensing; Tiffany Brake; Karl Münger; Paul F Lambert; Jeffrey M Arbeit
Journal:  Cancer Res       Date:  2003-08-15       Impact factor: 12.701

9.  DNA sequence of the HPV-16 E5 ORF and the structural conservation of its encoded protein.

Authors:  V Bubb; D J McCance; R Schlegel
Journal:  Virology       Date:  1988-03       Impact factor: 3.616

10.  Chronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice.

Authors:  J M Arbeit; P M Howley; D Hanahan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

View more
  6 in total

1.  A Novel In Vivo Model of Laryngeal Papillomavirus-Associated Disease Using Mus musculus Papillomavirus.

Authors:  Renee E King; Andrea Bilger; Josef Rademacher; Ella T Ward-Shaw; Rong Hu; Paul F Lambert; Susan L Thibeault
Journal:  Viruses       Date:  2022-05-08       Impact factor: 5.818

2.  Efficacy of Topically Administered Dihydroartemisinin in Treating Papillomavirus-Induced Anogenital Dysplasia in Preclinical Mouse Models.

Authors:  Laura C Gunder; Simon Blaine-Sauer; Hillary R Johnson; Myeong-Kyun Shin; Andrew S Auyeung; Wei Zhang; Glen E Leverson; Ella T Ward-Shaw; Renee E King; Stephanie M McGregor; Kristina A Matkowskyj; Paul F Lambert; Evie H Carchman
Journal:  Viruses       Date:  2022-07-26       Impact factor: 5.818

3.  MmuPV1-Induced Cutaneous Squamous Cell Carcinoma Arises Preferentially from Lgr5+ Epithelial Progenitor Cells.

Authors:  Ruben Moreno; Darya Buehler; Paul F Lambert
Journal:  Viruses       Date:  2022-08-11       Impact factor: 5.818

Review 4.  Mus musculus Papillomavirus 1: a New Frontier in Animal Models of Papillomavirus Pathogenesis.

Authors:  Megan E Spurgeon; Paul F Lambert
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

5.  An Infection-Based Murine Model for Papillomavirus-Associated Head and Neck Cancer.

Authors:  Tao Wei; Darya Buehler; Ella Ward-Shaw; Paul F Lambert
Journal:  mBio       Date:  2020-05-12       Impact factor: 7.867

6.  A Novel Model for Papillomavirus-Mediated Anal Disease and Cancer Using the Mouse Papillomavirus.

Authors:  Simon Blaine-Sauer; Myeong-Kyun Shin; Kristina A Matkowskyj; Ella Ward-Shaw; Paul F Lambert
Journal:  mBio       Date:  2021-07-20       Impact factor: 7.867

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.